Display options
Cite
Rong C, Feng Y, Ye Z. Notch is a critical regulator in cervical cancer by regulating Numb splicing. Oncol Lett. 2017;13(4):2465-2470doi: 10.3892/ol.2017.5683.
Rong, C., Feng, Y., & Ye, Z. (2017). Notch is a critical regulator in cervical cancer by regulating Numb splicing. Oncology letters, 13(4), 2465-2470. https://doi.org/10.3892/ol.2017.5683
Rong, Cai, et al. "Notch is a critical regulator in cervical cancer by regulating Numb splicing." Oncology letters vol. 13,4 (2017): 2465-2470. doi: https://doi.org/10.3892/ol.2017.5683
Rong C, Feng Y, Ye Z. Notch is a critical regulator in cervical cancer by regulating Numb splicing. Oncol Lett. 2017 Apr;13(4):2465-2470. doi: 10.3892/ol.2017.5683. Epub 2017 Feb 07. PMID: 28454421; PMCID: PMC5403445.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2017 Apr;13(4):2465-2470. doi: 10.3892/ol.2017.5683. Epub 2017 Feb 07.

Notch is a critical regulator in cervical cancer by regulating Numb splicing.

Oncology letters

Cai Rong, Yu Feng, Zhou Ye

Affiliations

  1. Department of Gynaecology and Obstetrics, The Affiliated Wuxi Second Hospital, Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China.

PMID: 28454421 PMCID: PMC5403445 DOI: 10.3892/ol.2017.5683

Abstract

Cervical cancer, which is the second most common female malignancy, is characterized by the consistent presence of human papillomavirus. Inappropriate activation of Notch signaling has been associated with various types of cancer; however, the role of Notch in cervical cancer remains unclear. The present study aimed to investigate the role of Notch in cervical cancer. The methods used included the generation of plasmids, viability assays, polymerase chain reaction and western blotting The present findings demonstrated that cervical cancer samples also consistently exhibit abnormal activation of the Notch pathway. The data also indicated that different Numb isoforms may have opposite effects on the proliferation of cervical cancer cells. As a result, the activated Notch signaling pathway regulates the alternative splicing of the Numb gene, which affects the proliferation of the cervical cancer cells. These findings suggest that activated Notch signaling may lead to the development of cervical cancer by regulating Numb splicing. Thus, Numb splice variants may be a potential clinical marker for indicating cervical cancer genesis and development.

Keywords: Notch; Numb; cervical cancer; human papillomavirus; thinprep cytology test

References

  1. Exp Cell Res. 2010 Apr 1;316(6):900-6 - PubMed
  2. J Cell Mol Med. 2007 Jul-Aug;11(4):881-91 - PubMed
  3. Curr Opin Chem Biol. 2002 Aug;6(4):501-9 - PubMed
  4. Genes Dev. 2002 Sep 1;16(17):2252-63 - PubMed
  5. Am Fam Physician. 2012 Sep 15;86(6):563-4 - PubMed
  6. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10472-6 - PubMed
  7. Nat Genet. 2003 Mar;33(3):416-21 - PubMed
  8. Int J Cancer. 1974 May 15;13(5):657-64 - PubMed
  9. Asian Pac J Cancer Prev. 2011;12(5):1149-53 - PubMed
  10. J Cell Physiol. 2003 Mar;194(3):356-62 - PubMed
  11. Przegl Lek. 2012;69(9):651-7 - PubMed
  12. Gan To Kagaku Ryoho. 2013 Feb;40(2):165-9 - PubMed
  13. Ginekol Pol. 2012 Aug;83(8):572-5 - PubMed
  14. Nat Rev Cancer. 2011 May;11(5):338-51 - PubMed
  15. Curr Opin Genet Dev. 2004 Feb;14(1):48-54 - PubMed
  16. Oncologist. 2012;17(2):220-32 - PubMed
  17. Mol Diagn Ther. 2008;12(6):395-400 - PubMed
  18. Cancer Res. 2003 Dec 1;63(23):8323-9 - PubMed
  19. Eur Rev Med Pharmacol Sci. 2012 Dec;16(14 ):1994-8 - PubMed
  20. Mol Cell Biol. 1998 Apr;18(4):2324-33 - PubMed
  21. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6414-8 - PubMed
  22. Mol Cell Biol. 2011 Jan;31(1):138-50 - PubMed
  23. Semin Cancer Biol. 2004 Oct;14(5):320-8 - PubMed
  24. DNA Cell Biol. 2013 Jan;32(1):19-27 - PubMed
  25. Oncogene. 1999 Oct 28;18(44):5973-81 - PubMed
  26. J Biol Chem. 2003 Jun 20;278(25):23196-203 - PubMed
  27. Asian Pac J Cancer Prev. 2013;14(5):2979-82 - PubMed
  28. Neuron. 1996 Jul;17(1):27-41 - PubMed
  29. Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):204-8 - PubMed
  30. Cancer Lett. 2005 Feb 28;219(1):113-20 - PubMed
  31. Blood. 2006 Mar 15;107(6):2223-33 - PubMed
  32. J Biol Chem. 2009 Sep 25;284(39):26427-38 - PubMed
  33. J Biol Chem. 1999 Nov 12;274(46):33097-104 - PubMed
  34. Semin Cancer Biol. 2004 Oct;14(5):317-9 - PubMed
  35. Lancet. 2005 Sep 17-23;366(9490):991-8 - PubMed
  36. Cancer Res. 2001 Oct 1;61(19):7291-7 - PubMed
  37. Virology. 2001 Jul 20;286(1):23-30 - PubMed
  38. PLoS Genet. 2014 Apr 10;10(4):e1004289 - PubMed
  39. Przegl Lek. 2012;69(10):740-3 - PubMed

Publication Types